Table 1 Patients’ characteristics
Parameter | BIOMESH group n = 32 | Control group n = 32 | p |
|---|---|---|---|
Sex (M/F) | 18/14 | 17/15 | 1 |
Pathology (colon/ovarian) | 25/7 | 27/5 | 1 |
Bevacizumab (n) | 3/32 | 3/32 | 1 |
Age (years) | 58.63 ± 4.8 | 59.13 ± 4.4 | 0.70 |
Defect size (cm) | 7.47 ± 3 | 7.64 ± 2.5 | 0.83 |
BMI (kg/m2) | 25.4 ± 3.1 | 25.6 ± 2.3 | 0.80 |
ASA score III | 46.8 % (15/32) | 53.1 % (17/32) | 0.77 |